Skip to search formSkip to main contentSkip to account menu

enocitabine

Known as: BH-AC, Docosanamide, N-(1-beta-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, N(4)-behenoyl ara-C 
A pyrimidine antimetabolite converted to Cytarabine in the body. (NCI)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
We conducted a phase 1 study of a combination of gemtuzumab ozogamicin (GO) plus conventional chemotherapy in elderly patients… 
2009
2009
We investigated the outcome of idarubicin plus N4-behenoyl-1-β-D-arabinofuranosyl cytosine (BHAC)-based chemotherapy (BHAC group… 
2006
2006
This study analysed the clinical outcome of salvage therapy consisting of aclarubicin (ACR) plus behenoyl cytarabine (BHAC) and… 
2001
2001
We describe a variant form, French-American-British (FAB) M3v, of acute promyelocytic leukemia (APL; FAB M3) with atypical… 
2000
2000
To clarify the release properties of anti-cancer drugs from fibrin glue, a study was performed using several anti-cancer drugs… 
1997
1997
Abstract We analyzed the results of treating patients with newly diagnosed acute promyelocytic leukemia (APL) with all-trans… 
1997
1997
We analyzed the results of treating patients with newly diagnosed acute promyelocytic leukemia (APL) with all-trans retinoic acid… 
1987
1987
Winged beans were extracted with hexane and the extracted lipid was analyzed by HPLC for its triacylglycerol (triglyceride…